Skip to main content
. 2021 Aug 13;13(8):1252. doi: 10.3390/pharmaceutics13081252

Table 4.

Analysis of chronic toxicity of formulation L in C57Bl/6 mice. Complete blood count of animals after four intravenous (IV) administrations of liposomal formulation L or saline buffer.

Blood Parameter Day 0 1 OptiMEM L
1 TD 2 2 TD 2
Day 21 Day 60 Day 21 Day 60 Day 21 Day 60
Leukocytes × 109/L 2.5 ± 0.2 3.9 ± 0.1 3.0 ± 0.3 3.1 ± 0.2 2.7 ± 0.4 2.6 ± 0.3 2.4 ± 0.2
Lymphocytes × 109/L 2.2 ± 0.2 2.9 ± 0.3 2.5 ± 0.2 2.6 ± 0.2 2.4 ± 0.4 2.2 ± 0.2 1.9 ± 0.2
Monocytes × 109/L 0.2 ± 0.1 0.5 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
Granulocytes × 109/L 0.2 ± 0.1 0.5 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.2 ± 0.1
Erythrocytes × 1012/L 9.7 ± 0.3 9.0 ± 0.2 8.6 ± 0.2 9.4 ± 0.2 8.7 ± 0.5 9.0 ± 0.2 8.8 ± 0.2
Thrombocytes × 109/L 514 ± 94.8 833 ± 113 757 ± 45.9 776 ± 43.6 735 ± 74.9 920 ± 39.9 757 ± 52.3
Hemoglobin g/L 128 ± 4.1 107 ± 3.4 107 ± 3.1 113 ± 2.9 105 ± 5.9 111 ± 3.1 115 ± 3.7

1 Day 0 indicates the initial levels of blood parameters before treatment; 2 TD, therapeutic dose; 1 TD corresponds to 1.5 nmol/g of liposomes.